CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment Date: March 24, 2021 By: echo_wpbaycrest_admin Categories: Session 04: Screening, Assessment & Diagnosis of Dementia Read More
CCCDTD5: Reducing the risk of later-life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia Date: March 24, 2021 By: echo_wpbaycrest_admin Categories: Session 04: Screening, Assessment & Diagnosis of Dementia Read More
CCCDTD5: Individual and community-based psychosocial and other non-pharmacological interventions to support persons living with dementia and their caregivers Date: March 24, 2021 By: echo_wpbaycrest_admin Categories: Session 04: Screening, Assessment & Diagnosis of Dementia Read More
Canadian Study of Health and Aging: study methods and prevalence of dementia Date: March 24, 2021 By: echo_wpbaycrest_admin Categories: Session 04: Screening, Assessment & Diagnosis of Dementia Read More
Brief cognitive screening instruments: an update Date: March 24, 2021 By: echo_wpbaycrest_admin Categories: Session 04: Screening, Assessment & Diagnosis of Dementia Read More
The delirium experience: what is the effect on patients, relatives and staff and what can be done to modify this? Date: March 24, 2021 By: echo_wpbaycrest_admin Categories: Session 03: Delirium Read More
Promoting vision and hearing aids use in an intensive care unit Date: March 24, 2021 By: echo_wpbaycrest_admin Categories: Session 03: Delirium Read More
Non-pharmacological Interventions for preventing delirium in hospitalised non-ICU patients (Protocol) Date: March 24, 2021 By: echo_wpbaycrest_admin Categories: Session 03: Delirium Read More
Neurologic Features in Severe SARS-CoV-2 Infection Date: March 24, 2021 By: echo_wpbaycrest_admin Categories: Session 03: Delirium Read More
Neural Mechanisms of Delirium Date: March 24, 2021 By: echo_wpbaycrest_admin Categories: Session 03: Delirium Read More
